首页> 美国卫生研究院文献>Oncology Letters >Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells
【2h】

Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells

机译:环氧合酶-2沉默对MCF-7乳腺癌细胞恶性生物学行为的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to investigate the effect of cyclooxygenase-2 (COX-2) silencing on the malignant biological behavior of MCF-7 breast cancer cells. COX-2 short hairpin RNA (shRNA) and unassociated sequences were synthesized and a shRNA lentiviral vector was constructed. The vector was transfected into MCF-7 breast cancer cells, in which clones with stable expression were screened out. The expression of COX-2 mRNA and protein was silenced using RNA interference (RNAi). Quantitative polymerase chain reaction, western blotting, a mononuclear cell direct cytotoxicity assay (MTT assay), a cell invasion assay and scratch tests were performed to investigate the downregulation of COX-2 mRNA and protein expression, the proliferative activity and growth rate of MCF-7 breast cancer cells, the glioblastoma multiforme (GBM) penetrating capacity, the cell movement and migratory capacity, and vascular endothelial growth factor (VEGF)-A and VEGF-C protein expression. The results revealed that the sequence-specific shRNA significantly downregulated the expression of COX-2 at the mRNA and protein levels. Furthermore, the downregulation of COX-2 expression markedly decreased the invasive and metastatic capacities of the cells, suppressed the proliferation, decreased the rate of growth, decreased the capacity of GBM penetration and migration, and decreased the protein expression of VEGF-A and VEGF-C, the two key factors that regulate tumor angiogenesis and lymphangiogenesis. In conclusion, the RNAi technique effectively silenced COX-2 gene expression and inhibited MCF-7 breast cancer cell proliferation, invasion and metastasis by decreasing VEGF-A and VEGF-C expression, which regulates tumor angiogenesis and lymphangiogenesis. Therefore, an RNAi technique that targets COX-2 presents a promising prospect for breast cancer gene therapy.
机译:本研究的目的是研究环氧合酶2(COX-2)沉默对MCF-7乳腺癌细胞恶性生物学行为的影响。合成了COX-2短发夹RNA(shRNA)和不相关的序列,并构建了shRNA慢病毒载体。将该载体转染到MCF-7乳腺癌细胞中,筛选出表达稳定的克隆。使用RNA干扰(RNAi)沉默COX-2 mRNA和蛋白质的表达。进行了定量聚合酶链反应,蛋白质印迹,单核细胞直接细胞毒性试验(MTT试验),细胞侵袭试验和刮擦试验,以研究COX-2 mRNA和蛋白表达的下调,MCF-的增殖活性和生长速率。 7种乳腺癌细胞的多形性胶质母细胞瘤(GBM)的穿透能力,细胞运动和迁移能力以及血管内皮生长因子(VEGF)-A和VEGF-C蛋白的表达。结果表明,序列特异性shRNA在mRNA和蛋白水平上显着下调了COX-2的表达。此外,COX-2表达的下调显着降低了细胞的侵袭和转移能力,抑制了增殖,降低了生长速度,降低了GBM渗透和迁移的能力,并降低了VEGF-A和VEGF的蛋白表达。 -C,调节肿瘤血管生成和淋巴管生成的两个关键因素。总之,RNAi技术可通过降低VEGF-A和VEGF-C的表达来有效沉默COX-2基因的表达并抑制MCF-7乳腺癌细胞的增殖,侵袭和转移,从而调节肿瘤血管生成和淋巴管生成。因此,靶向COX-2的RNAi技术为乳腺癌基因治疗提供了有希望的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号